Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) EBIT Margin (2017 - 2025)

Catheter Precision has reported EBIT Margin over the past 9 years, most recently at 4143.28% for Q4 2025.

  • Quarterly EBIT Margin fell 209563.0% to 4143.28% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2581.56% through Dec 2025, up 9534.0% year-over-year, with the annual reading at 2581.56% for FY2025, 9534.0% up from the prior year.
  • EBIT Margin was 4143.28% for Q4 2025 at Catheter Precision, down from 1336.73% in the prior quarter.
  • Over five years, EBIT Margin peaked at 720.6% in Q2 2021 and troughed at 171750.0% in Q1 2021.
  • The 5-year median for EBIT Margin is 3084.18% (2024), against an average of 45898.43%.
  • Year-over-year, EBIT Margin tumbled -17118304bps in 2021 and then soared 16262917bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 165280.0% in 2021, then decreased by -2bps to 169200.0% in 2022, then surged by 99bps to 2028.91% in 2023, then dropped by -1bps to 2047.65% in 2024, then crashed by -102bps to 4143.28% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's EBIT Margin are 4143.28% (Q4 2025), 1336.73% (Q3 2025), and 2210.38% (Q2 2025).